Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Return on Equity (2016 - 2026)

Akebia Therapeutics has reported Return on Equity over the past 10 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Equity fell 2.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, down 2.0% year-over-year, with the annual reading at 0.01% for FY2025, 1.0% down from the prior year.
  • Return on Equity was 0.0% for Q4 2025 at Akebia Therapeutics, up from 0.0% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.08% in Q1 2023 and troughed at 0.14% in Q4 2022.
  • The 5-year median for Return on Equity is 0.0% (2025), against an average of 0.01%.
  • Year-over-year, Return on Equity decreased -12bps in 2022 and then rose 16bps in 2023.
  • A 5-year view of Return on Equity shows it stood at 0.03% in 2021, then tumbled by -431bps to 0.14% in 2022, then surged by 110bps to 0.01% in 2023, then decreased by -6bps to 0.01% in 2024, then tumbled by -110bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Return on Equity are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.01% (Q2 2025).